Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KUKJEON PHARMACEUTICAL Co., Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic mate… Read more
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd - Asset Resilience Ratio
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750) has an Asset Resilience Ratio of 9.26% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩16.46 Billion | 9.26% |
| Total Liquid Assets | ₩16.46 Billion | 9.26% |
Asset Resilience Insights
- Limited Liquidity: Daishin Balance No.6 Special Purpose Acquisition Co. Ltd maintains only 9.26% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Novartis AG
PINK:NVSEF |
Drug Manufacturers - General | 0.13% |
|
Pfizer Inc
NYSE:PFE |
Drug Manufacturers - General | 7.18% |
|
AbbVie Inc
NYSE:ABBV |
Drug Manufacturers - General | 0.02% |
|
Biogen Inc
NASDAQ:BIIB |
Drug Manufacturers - General | 2.74% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
Drug Manufacturers - General | 5.75% |
|
Hunan Jingfeng Pharmaceutical
SHE:000908 |
Drug Manufacturers - General | 0.38% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
Annual Asset Resilience Ratio for Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (2020–2024)
The table below shows the annual Asset Resilience Ratio data for Daishin Balance No.6 Special Purpose Acquisition Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 22.05% | ₩46.81 Billion | ₩212.27 Billion | -6.74pp |
| 2023-12-31 | 28.79% | ₩64.82 Billion | ₩225.10 Billion | -19.63pp |
| 2022-12-31 | 48.43% | ₩94.96 Billion | ₩196.10 Billion | +29.58pp |
| 2021-12-31 | 18.84% | ₩20.16 Billion | ₩106.99 Billion | +18.53pp |
| 2020-12-31 | 0.31% | ₩180.00 Million | ₩57.80 Billion | -- |